Lv2
108 积分 2025-04-27 加入
Comparison of Darifenacin and Oxybutynin in Patients with Overactive Bladder: Assessment of Ambulatory Urodynamics and Impact on Salivary Flow
16天前
已完结
Pharmacological characterization of DA-8010, a novel muscarinic receptor antagonist selective for urinary bladder over salivary gland
16天前
已完结
Pharmacological Effects of Imidafenacin (KRP-197/ONO-8025), a New Bladder Selective Anti-cholinergic Agent, in Rats
16天前
已完结
Advantages for Transdermal over Oral Oxybutynin to Treat Overactive Bladder: Muscarinic Receptor Binding, Plasma Drug Concentration, and Salivary Secretion
16天前
已完结
Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice
16天前
已完结
Effects of Intravenously and Orally Administered Solifenacin Succinate (YM905) on Carbachol-Induced Intravesical Pressure Elevation and Salivary Secretion in Mice
16天前
已完结
Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice
16天前
已完结
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats
16天前
已完结
V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results
16天前
已完结
Characterization of V0162, a new long-acting antagonist at human M3 muscarinic acetylcholine receptors
16天前
已完结
皖公网安备34019202002308
